Ironwood Pharmaceuticals, Inc.'s revenue has shrunk 3.0% a year over three years, and shrunk 1.2% a year over five. Revenue growth, 3-year annual rate: −3.0% (Drug Manufacturers - Specialty & Generic median +12%). Revenue growth, 5-year rate: −1.2%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

IRWDIronwood Pharmaceuticals, Inc.

Healthcare

$3.46+120% 1Y

$3.46

$1.5052 weeks$5.39

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +26% year on year and operating margin widening (+42.3 points), but earnings down −1383% year on year.

2 good, 1 to watch

Revenue trend+26% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −1% a year.

Earnings trend−1383% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+42.3 points operating

Trailing-twelve-month operating margin, 53.6% now against 11.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IRWD growing?

Ironwood Pharmaceuticals, Inc.'s revenue has shrunk 3.0% a year over three years, and shrunk 1.2% a year over five.

−3.0%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +12% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −1.2%
Revenue growth, 5-year rate · −3.0% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›